APLT: Applied Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment of diabetic retinopathy which are in clinical stage. Applied Therapeutics Inc. is based in New York, United States.

Info & Links

CEO

Shoshana Shendelman

Headquarters

545 5TH AVENUE, SUITE 1400
NEW YORK, NY 10017, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

Applied Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

63.18M

Enterprise Value

-35.69M

Enterprise Value/EBITDA(ttm)

0.39

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

11.02

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

Profit Margin(ttm)

-23184.62%

Return on Equity(ttm)

-260.75%

Return on Invested Capital(ttm)

-1065.11%

Return on Assets(ttm)

-76.04%

Income Statement

Revenue(ttm)

-211.00K

Revenue Per Share(ttm)

-0.00

Gross Profit(ttm)

-211.00K

EBITDA(ttm)³

-90.98M

Net Income Available to Common(ttm)

-187.31M

Diluted EPS(ttm)

-1.61

Share Statistics

Beta (5Y Monthly)

1.88

52-Week Change

-90.54%

S&P 500 52-Week Change

18.86%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

116.36M

Dividend Yield

0.00%

Float⁴

106.35M

% Held by Insiders

8.60%

% Held by Institutions

98.31%

Balance Sheet

Total Cash(mrq)

98.87M

Total Cash Per Share(mrq)

0.85

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.06%

Quick Ratio(mrq)

1.06%

Book Value Per Share(mrq)

0.05

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.45

Free Cash Flow(ytd)

-64.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

APLT

Applied Therapeutics, Inc. Common Stock

Applied Therapeutics, Inc. Common Stock Profile